Susceptibility Studies of Novel Antimicrobial Drugs Against Carbapenem‐Resistant and Hypervirulent <i>Klebsiella pneumoniae</i>
Cefiderocol appears highly promising as a therapy for CR-hvKP infections. Our findings will not only effectively address the challenge of CR-hvKP resistance, but also provide evidence to support the optimization of clinical therapeutic strategies and further promote the development and application of novel antimicrobial drugs.
Authors
- Xun Jia
- Yulian Li (ORCID: https://orcid.org/0009-0009-9269-9093)
- Huinan Mao
- Jie Yang (ORCID: https://orcid.org/0000-0003-4801-7162)
- Yi Li (ORCID: https://orcid.org/0000-0003-2226-5918)
- Dan Li
- Jie Zhang
- Xiao Wang
Institutions
- University of Electronic Science and Technology of China (CN)
- Chengdu Medical College (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Evidence-Based Medicine
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1111/jebm.70113
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Science and Technology Major Project